Marc Frahm
Stock Analyst at TD Cowen
(4.81)
# 496
Out of 4,405 analysts
410
Total ratings
51.1%
Success rate
18.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Marc Frahm
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DMRA Damora Therapeutics | Maintained: Buy | n/a | $20.78 | - | 2 | Jun 11, 2026 | |
| CGEM Cullinan Therapeutics | Maintained: Buy | n/a | $13.70 | - | 25 | Jun 10, 2026 | |
| NUVL Nuvalent | Downgraded: Hold | $124 | $123.25 | +0.61% | 17 | Jun 10, 2026 | |
| INCY Incyte | Maintained: Buy | $124 | $108.53 | +14.25% | 69 | Jun 9, 2026 | |
| CRDF Cardiff Oncology | Maintained: Hold | n/a | $1.54 | - | 16 | Jun 4, 2026 | |
| AGIO Agios Pharmaceuticals | Maintained: Buy | n/a | $29.46 | - | 23 | Jun 2, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | n/a | $153.87 | - | 24 | Jun 1, 2026 | |
| ACRV Acrivon Therapeutics | Maintained: Buy | n/a | $1.48 | - | 12 | May 14, 2026 | |
| SANA Sana Biotechnology | Maintained: Buy | n/a | $2.68 | - | 14 | May 11, 2026 | |
| NKTR Nektar Therapeutics | Reiterated: Buy | n/a | $59.38 | - | 2 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $7.33 | -31.79% | 11 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $15 | $16.62 | -9.75% | 19 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $13.56 | - | 18 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $44.18 | - | 23 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.75 | - | 15 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.94 | - | 13 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $18.24 | - | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $86.21 | - | 22 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.31 | - | 10 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.0315 | n/a | 19 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.00 | n/a | 8 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $82.07 | n/a | 10 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $150,000.00 | n/a | 6 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $14.85 | n/a | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.90 | n/a | 3 | Aug 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $33.10 | n/a | 5 | Feb 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1,133.00 | n/a | 1 | Jan 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $264.48 | n/a | 6 | Dec 4, 2018 |
Damora Therapeutics
Jun 11, 2026
Maintained: Buy
Price Target: n/a
Current: $20.78
Upside: -
Cullinan Therapeutics
Jun 10, 2026
Maintained: Buy
Price Target: n/a
Current: $13.70
Upside: -
Nuvalent
Jun 10, 2026
Downgraded: Hold
Price Target: $124
Current: $123.25
Upside: +0.61%
Incyte
Jun 9, 2026
Maintained: Buy
Price Target: $124
Current: $108.53
Upside: +14.25%
Cardiff Oncology
Jun 4, 2026
Maintained: Hold
Price Target: n/a
Current: $1.54
Upside: -
Agios Pharmaceuticals
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $29.46
Upside: -
Revolution Medicines
Jun 1, 2026
Maintained: Buy
Price Target: n/a
Current: $153.87
Upside: -
Acrivon Therapeutics
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $1.48
Upside: -
Sana Biotechnology
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $2.68
Upside: -
Nektar Therapeutics
May 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $59.38
Upside: -
May 8, 2026
Maintained: Hold
Price Target: $5
Current: $7.33
Upside: -31.79%
May 8, 2026
Rated: Hold
Price Target: $15
Current: $16.62
Upside: -9.75%
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $13.56
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $44.18
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $1.75
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $4.94
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $18.24
Upside: -
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $86.21
Upside: -
Nov 13, 2025
Maintained: Buy
Price Target: n/a
Current: $8.31
Upside: -
Nov 14, 2024
Maintained: Buy
Price Target: n/a
Current: $0.0315
Upside: n/a
Jan 12, 2024
Rated: Hold
Price Target: n/a
Current: $4.00
Upside: n/a
Jan 26, 2023
Downgraded: Hold
Price Target: n/a
Current: $82.07
Upside: n/a
Mar 22, 2021
Downgraded: Hold
Price Target: n/a
Current: $150,000.00
Upside: n/a
Mar 2, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $14.85
Upside: n/a
Aug 5, 2020
Maintained: Buy
Price Target: n/a
Current: $1.90
Upside: n/a
Feb 26, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $33.10
Upside: n/a
Jan 7, 2019
Downgraded: Hold
Price Target: n/a
Current: $1,133.00
Upside: n/a
Dec 4, 2018
Maintained: Buy
Price Target: n/a
Current: $264.48
Upside: n/a